Get 20% lifetime commission for referring investors to digrin.com
here.
Humacyte, Inc. ( HUMA) - Key Metrics
HUMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.16 | -$0.09 | -$0.09 |
| 2026Q1 | $0 | -$0.09 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.16 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.11 | -$0.15 | -$0.15 |
| 2025Q2 | $0 | -$0.24 | -$0.17 | -$0.17 |
HUMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.22 |
| 2026Q1 | 0% | -1.70 |
| 2025Q4 | 0% | -1.60 |
| 2025Q3 | 0% | -3.95 |
| 2025Q2 | 0% | -2.18 |
HUMA
Price: $0.58
52 week price:
Earnings Per Share: -0.43 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 166552
Market Capitalization: 148.3 million